BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3877806)

  • 1. Early pregnancy interruption with a single PGF2 alpha 15-methyl-analogue vaginal suppository.
    Borten M; Friedman EA
    J Reprod Med; 1985 Oct; 30(10):741-4. PubMed ID: 3877806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study on the interruption of first and second trimester pregnancies by vaginal suppositories of dl-15 methyl PGF2 alpha methyl ester].
    Fan GS; Xu YD; Wu YM; Hu CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):65-8. PubMed ID: 2954692
    [No Abstract]   [Full Text] [Related]  

  • 5. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP; Brenner PF; Roy S; Mishell DR
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual regulation with prostaglandin analogues.
    Hagenfeldt K; Bygdeman M
    Reproduccion; 1981; 5(3):195-201. PubMed ID: 7026317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS; Stiber AJ; Turkel J
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S; Brenner PF; Marrs RP; Mishell DR
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
    Lauersen NH; Wilson KH
    Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994
    [No Abstract]   [Full Text] [Related]  

  • 13. Interruption of early first trimester pregnancy by single vaginal administration of 15-methyl-pgf2 alpha-methyl ester.
    Gréen K; Bygdeman M; Bremme K
    Contraception; 1978 Dec; 18(6):551-60. PubMed ID: 750185
    [No Abstract]   [Full Text] [Related]  

  • 14. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative cervical dilatation with a single long-acting prostaglandin analog suppository. An alternative to traumatic mechanical dilatation before surgical evacuation.
    Kent DR; Goldstein AI; Milokovich D
    J Reprod Med; 1983 Nov; 28(11):778-80. PubMed ID: 6655636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of 15-methyl PGF2-alpha for termination of early pregnancy].
    Manuilova IA; Murashko LE; Fanchenko ND; Kolod'ko VG
    Sov Med; 1980; (3):49-53. PubMed ID: 7376012
    [No Abstract]   [Full Text] [Related]  

  • 17. [New considerations in therapeutic abortions using a second generation prostaglandins (author's transl)].
    Steiner H; Zahradnik HP; Breckwoldt M; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):464-9. PubMed ID: 478257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postconception menses induction using prostaglandin vaginal suppositories.
    Foster HW; Smith M; McGruder CE; Richard F; McIntyre J
    Obstet Gynecol; 1985 May; 65(5):682-5. PubMed ID: 3982746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of prostaglandins and their analogues for abortion.
    Bygdeman M
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.